Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)
Pharmaceutical Preparations
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
05/07/2018
Market Cap
2,487,178,069
Shares Outstanding
306,540,000
Weighted SO
306,544,199
Total Employees
N/A
Upcoming Earnings
08/09/2024
Beta
1.2310
Last Div
0.0000
Range
3.36-8.15
Chg
0.1250
Avg Vol
1472085
Mkt Cap
2487178069
Exch
NYSE
Country
US
Phone
908 947 3120
DCF Diff
-14.0833
DCF
22.1183
Div Yield
0.0000
P/S
0.9573
EV Multiple
18.4064
P/FV
-43.2220
Div Yield %
0.0000
P/E
-15.1612
PEG
-1.4630
Payout
0.0000
Current Ratio
1.3330
Quick Ratio
0.8165
Cash Ratio
0.0393
DSO
108.1616
DIO
124.4960
Op Cycle
232.6575
DPO
0.0000
CCC
232.6575
Gross Margin
0.3504
Op Margin
0.0672
Pretax Margin
-0.0445
Net Margin
-0.0631
Eff Tax Rate
-0.1521
ROA
-0.0467
ROE
-12.4043
ROCE
0.0729
NI/EBT
1.4169
EBT/EBIT
-0.6623
EBIT/Rev
0.0672
Debt Ratio
0.7254
D/E
-44.3076
LT Debt/Cap
1.0259
Total Debt/Cap
1.0231
Int Coverage
-8.3265
CF/Debt
0.0791
Equity Multi
-61.0793
Rec Turnover
3.3746
Pay Turnover
0.0000
Inv Turnover
2.9318
FA Turnover
4.9117
Asset Turnover
0.7402
OCF/Share
0.6517
FCF/Share
0.4019
Cash/Share
0.1416
OCF/Sales
0.0775
FCF/OCF
0.6167
CF Coverage
0.0791
ST Coverage
0.7389
CapEx Coverage
2.6091
Div&CapEx Cov
2.6091
P/BV
-43.2220
P/B
-43.2220
P/S
0.9573
P/E
-15.1612
P/FCF
20.0187
P/OCF
12.3291
P/CF
12.3291
PEG
-1.4630
P/S
0.9573
EV Multiple
18.4064
P/FV
-43.2220
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 497.53M | ▼ 397.33M | ▲ 510.03M | ▲ 536.90M | ▲ 609.76M | ▲ 616.98M | ▲ 659.19M |
Cost Of Revenue | 304.12M | ▼ 287.09M | ▲ 342.96M | ▲ 370.49M | ▲ 394.37M | ▲ 427.15M | ▼ 421.13M |
Gross Profit | 193.41M | ▼ 110.23M | ▲ 167.07M | ▼ 166.40M | ▲ 215.39M | ▼ 189.83M | ▲ 238.06M |
Gross Profit Ratio | 0.39 | ▼ 0.28 | ▲ 0.33 | ▼ 0.31 | ▲ 0.35 | ▼ 0.31 | ▲ 0.36 |
Research And Development Expenses | 60.53M | ▼ 53.03M | ▲ 57.16M | ▼ 53.02M | ▼ 43.27M | ▲ 46.56M | ▼ 39.30M |
General And Administrative Expenses | 71.24M | ▲ 151.72M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling And Marketing Expenses | 0.00 | ▼ -77.63M | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 71.24M | ▲ 74.08M | ▲ 84.69M | ▲ 97.22M | ▲ 102.16M | ▲ 109.00M | ▲ 112.60M |
Other Expenses | 2.12M | ▼ -197.00K | ▲ 488.00K | ▲ 6.63M | ▼ -1.47M | ▲ 411.00K | ▲ 4.07M |
Operating Expenses | 131.77M | ▼ 127.11M | ▲ 141.85M | ▲ 150.24M | ▼ 143.96M | ▲ 155.57M | ▼ 151.89M |
Cost And Expenses | 435.89M | ▼ 414.20M | ▲ 484.81M | ▲ 520.73M | ▲ 538.33M | ▲ 582.72M | ▼ 573.02M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 47.03M | ▼ -100.17M | ▲ 0.00 |
Interest Expense | 42.88M | ▼ 38.83M | ▼ 34.54M | ▼ 33.96M | ▲ 47.03M | ▲ 59.55M | ▼ -65.70M |
Depreciation And Amortization | 47.49M | ▲ 54.30M | ▲ 59.87M | ▲ 61.18M | ▼ 61.06M | ▼ 56.93M | ▼ 55.53M |
Ebitda | 63.76M | ▼ 37.23M | ▼ 25.71M | ▲ 83.98M | ▲ 135.25M | ▼ 50.80M | ▼ -10.75M |
Ebitda Ratio | 0.13 | ▼ 0.09 | ▼ 0.05 | ▲ 0.16 | ▲ 0.22 | ▼ 0.08 | ▼ -0.02 |
Operating Income | 23.28M | ▼ -23.14M | ▲ 20.18M | ▼ 11.18M | ▲ 74.20M | ▼ 14.19M | ▼ -10.75M |
Operating Income Ratio | 0.05 | ▼ -0.06 | ▲ 0.04 | ▼ 0.02 | ▲ 0.12 | ▼ 0.02 | ▼ -0.02 |
Total Other Income Expenses Net | -33.56M | ▲ -1.41M | ▲ 3.83M | ▼ 1.48M | ▼ -81.85M | ▲ -17.37M | ▼ -64.78M |
Income Before Tax | -14.81M | ▼ -57.11M | ▲ -5.48M | ▼ -16.32M | ▲ -7.66M | ▼ -83.46M | ▲ -75.52M |
Income Before Tax Ratio | -0.03 | ▼ -0.14 | ▲ -0.01 | ▼ -0.03 | ▲ -0.01 | ▼ -0.14 | ▲ -0.11 |
Income Tax Expense | 5.52M | ▲ 7.79M | ▼ 1.49M | ▲ 4.14M | ▼ -1.80M | ▲ 9.88M | ▼ 6.16M |
Net Income | -8.77M | ▼ -32.13M | ▲ -3.04M | ▼ -6.38M | ▲ -5.86M | ▼ -98.65M | ▲ -91.64M |
Net Income Ratio | -0.02 | ▼ -0.08 | ▲ -0.01 | ▼ -0.01 | ▲ -0.01 | ▼ -0.16 | ▲ -0.14 |
Eps | -0.07 | ▼ -0.23 | ▲ -0.02 | ▼ -0.04 | -0.04 | ▼ -0.40 | ▲ -0.30 |
Eps Diluted | -0.07 | ▼ -0.23 | ▲ -0.02 | ▼ -0.04 | -0.04 | ▼ -0.40 | ▲ -0.30 |
Weighted Average Shs Out | 127.34M | ▲ 141.60M | ▲ 147.64M | ▲ 149.37M | ▲ 151.48M | ▲ 243.71M | ▲ 307.28M |
Weighted Average Shs Out Dil | 127.34M | ▲ 141.85M | ▲ 147.64M | ▲ 149.37M | ▲ 151.48M | ▲ 243.71M | ▲ 307.28M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 213.39M | ▼ 151.20M | ▲ 341.38M | ▼ 247.79M | ▼ 25.98M | ▲ 91.54M | ▼ 46.52M |
Short Term Investments | 2.14M | ▼ 1.12M | ▲ 1.70M | ▼ 1.17M | ▲ 1.82M | ▼ 0.00 | 0.00 |
Cash And Short Term Investments | 213.39M | ▼ 151.20M | ▲ 341.38M | ▼ 247.79M | ▼ 25.98M | ▲ 91.54M | ▼ 46.52M |
Net Receivables | 482.33M | ▲ 606.16M | ▲ 640.30M | ▲ 663.76M | ▲ 742.29M | ▼ 645.66M | ▲ 704.05M |
Inventory | 457.22M | ▼ 381.07M | ▲ 490.65M | ▼ 489.39M | ▲ 530.74M | ▲ 581.38M | ▼ 570.65M |
Other Current Assets | 128.32M | ▼ 70.16M | ▲ 73.47M | ▲ 110.22M | ▼ 103.57M | ▼ 91.21M | ▲ 93.92M |
Total Current Assets | 1.29B | ▼ 1.21B | ▲ 1.55B | ▼ 1.52B | ▼ 1.41B | ▼ 1.38B | ▲ 1.38B |
Property Plant Equipment Net | 544.15M | ▲ 609.15M | ▼ 595.17M | ▲ 639.00M | ▼ 589.36M | ▼ 550.14M | ▼ 544.79M |
Goodwill | 426.23M | ▼ 419.50M | ▲ 522.81M | ▲ 593.02M | ▲ 598.85M | ▼ 598.63M | ▼ 598.55M |
Intangible Assets | 1.65B | ▼ 1.38B | ▼ 1.30B | ▼ 1.17B | ▼ 1.10B | ▼ 890.42M | ▼ 859.27M |
Goodwill And Intangible Assets | 2.08B | ▼ 1.80B | ▲ 1.83B | ▼ 1.76B | ▼ 1.69B | ▼ 1.49B | ▼ 1.46B |
Long Term Investments | 0.00 | ▲ 16.37M | ▼ 0.00 | 0.00 | ▲ 85.59M | ▼ 0.00 | 0.00 |
Tax Assets | 373.16M | ▼ -16.37M | ▲ 0.00 | 0.00 | ▼ -85.59M | ▲ 0.00 | 0.00 |
Other Non Current Assets | 67.59M | ▼ 44.27M | ▼ 31.89M | ▼ 20.61M | ▲ 103.22M | ▼ 55.52M | ▲ 73.75M |
Total Non Current Assets | 3.07B | ▼ 2.46B | ▼ 2.45B | ▼ 2.42B | ▼ 2.39B | ▼ 2.09B | ▼ 2.08B |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 4.35B | ▼ 3.67B | ▲ 4.01B | ▼ 3.94B | ▼ 3.80B | ▼ 3.47B | ▼ 3.46B |
Account Payables | 514.44M | ▼ 507.48M | ▲ 613.66M | ▼ 583.35M | ▼ 538.20M | ▼ 143.57M | ▲ 175.33M |
Short Term Debt | 21.72M | ▲ 36.95M | ▲ 55.68M | ▼ 46.04M | ▲ 104.64M | ▲ 227.62M | ▲ 228.67M |
Tax Payables | 1.16M | ▲ 8.73M | ▼ 5.54M | ▼ 2.52M | ▼ 359.00K | ▼ 0.00 | 0.00 |
Deferred Revenue | 1.18M | ▼ -395.73M | ▼ -454.98M | ▲ -452.26M | ▲ 0.00 | ▲ 398.41M | ▲ 400.27M |
Other Current Liabilities | 16.52M | ▲ 401.70M | ▲ 462.54M | ▲ 500.12M | ▼ 109.96M | ▼ 76.99M | ▼ 30.13M |
Total Current Liabilities | 553.85M | ▼ 550.41M | ▲ 676.90M | ▲ 677.24M | ▲ 752.80M | ▲ 846.60M | ▼ 834.39M |
Long Term Debt | 2.67B | ▲ 2.73B | ▲ 2.89B | ▼ 2.83B | ▼ 2.74B | ▼ 2.52B | ▼ 2.52B |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 1.18M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 231.66M | ▼ 39.58M | ▲ 99.07M | ▼ 65.43M | ▲ 97.12M | ▼ 83.06M | ▲ 121.45M |
Total Non Current Liabilities | 2.90B | ▼ 2.77B | ▲ 2.98B | ▼ 2.90B | ▼ 2.84B | ▼ 2.61B | ▲ 2.64B |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 39.35M | ▲ 135.54M | ▼ 123.88M | ▲ 127.35M | ▼ 123.49M | ▼ 109.95M | ▲ 113.57M |
Total Liabilities | 3.46B | ▼ 3.32B | ▲ 3.66B | ▼ 3.57B | ▲ 3.59B | ▼ 3.45B | ▲ 3.47B |
Preferred Stock | 391.61M | ▼ 114.78M | ▼ 41.66M | ▼ 6.63M | ▼ 0.00 | ▲ 519.23M | ▼ 95.00K |
Common Stock | 2.99M | ▲ 2.99M | ▲ 3.00M | ▲ 3.01M | ▲ 3.04M | ▲ 3.07M | ▲ 3.09M |
Retained Earnings | -20.92M | ▼ -377.88M | ▲ -286.82M | ▲ -276.20M | ▼ -406.18M | ▼ -490.18M | ▼ -581.82M |
Accumulated Other Comprehensive Income Loss | -7.76M | ▲ -68.00K | ▼ -41.32M | ▲ -24.83M | ▲ 9.94M | ▼ -32.35M | ▲ -23.71M |
Other Total Stockholders Equity | 530.44M | ▲ 606.97M | ▲ 628.41M | ▲ 658.35M | ▼ 577.19M | ▼ 20.01M | ▲ 538.63M |
Total Stockholders Equity | 896.36M | ▼ 346.79M | ▼ 344.93M | ▲ 366.97M | ▼ 183.98M | ▼ 19.78M | ▼ -63.72M |
Total Equity | 1.29B | ▼ 461.57M | ▼ 386.59M | ▼ 373.61M | ▼ 208.93M | ▼ 20.01M | ▼ -16.61M |
Total Liabilities And Stockholders Equity | 4.35B | ▼ 3.67B | ▲ 4.01B | ▼ 3.94B | ▼ 3.80B | ▼ 3.47B | ▼ 3.46B |
Minority Interest | 391.61M | ▼ 114.78M | ▼ 41.66M | ▼ 6.63M | ▲ 24.95M | ▼ 230.00K | ▲ 47.12M |
Total Liabilities And Total Equity | 4.35B | ▼ 3.67B | ▲ 4.01B | ▼ 3.94B | ▼ 3.80B | ▼ 3.47B | ▼ 3.46B |
Total Investments | 2.14M | ▲ 17.50M | ▼ 1.70M | ▼ 1.17M | ▲ 87.41M | ▼ 0.00 | 0.00 |
Total Debt | 2.69B | ▲ 2.77B | ▲ 2.94B | ▼ 2.88B | ▼ 2.85B | ▼ 2.75B | ▼ 2.75B |
Net Debt | 2.48B | ▲ 2.61B | ▼ 2.60B | ▲ 2.63B | ▲ 2.82B | ▼ 2.66B | ▲ 2.70B |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -20.33M | ▼ -64.90M | ▲ -6.96M | ▼ -20.46M | ▲ -5.86M | ▼ -93.34M | ▲ -81.68M |
Depreciation And Amortization | 47.49M | ▲ 54.30M | ▲ 59.87M | ▲ 61.18M | ▼ 61.06M | ▼ 56.93M | ▼ 55.53M |
Deferred Income Tax | -328.00K | ▲ 33.00K | ▲ 11.81M | ▲ 42.80M | ▼ 0.00 | ▲ 9.88M | ▼ 0.00 |
Stock Based Compensation | 3.61M | ▲ 5.01M | ▲ 5.13M | ▲ 7.74M | ▲ 7.83M | ▼ 5.97M | ▲ 6.72M |
Change In Working Capital | 155.78M | ▼ -73.90M | ▲ 28.31M | ▼ -21.75M | ▼ -135.21M | ▲ 53.70M | ▼ -11.97M |
Accounts Receivables | 163.80M | ▼ -86.27M | ▲ 67.54M | ▼ -34.52M | ▼ -113.29M | ▲ 77.23M | ▼ -55.17M |
Inventory | 10.83M | ▼ 5.51M | ▼ -33.06M | ▲ 16.63M | ▼ -11.07M | ▼ -23.09M | ▲ -12.20M |
Accounts Payables | -28.35M | ▲ 3.68M | ▼ -21.43M | ▲ -11.11M | ▼ -55.87M | ▲ -19.76M | ▲ 62.17M |
Other Working Capital | 9.51M | ▼ 3.18M | ▲ 15.26M | ▼ 7.25M | ▲ 45.02M | ▼ 19.32M | ▼ 0.00 |
Other Non Cash Items | 73.43M | ▼ 28.56M | ▼ 7.80M | ▼ -6.25M | ▲ 48.89M | ▲ 102.68M | ▼ 1.64M |
Net Cash Provided By Operating Activities | 259.65M | ▼ -50.89M | ▲ 105.96M | ▼ 63.26M | ▼ -23.29M | ▲ 135.82M | ▼ -4.41M |
Investments In Property Plant And Equipment | -20.02M | ▲ -4.77M | ▼ -31.80M | ▲ -19.25M | ▲ -11.47M | ▼ -31.69M | ▲ -19.76M |
Acquisitions Net | 0.00 | ▼ -34.83M | ▲ 0.00 | ▼ -72.72M | ▲ 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 25.34M | ▲ 34.83M | ▼ -1.10M | ▲ 5.00M | ▼ -44.19M | ▲ -25.97M | ▲ -10.56M |
Net Cash Used For Investing Activities | 5.32M | ▼ -4.77M | ▼ -31.80M | ▼ -86.97M | ▲ -11.47M | ▼ -31.69M | ▲ -19.76M |
Debt Repayment | -159.01M | ▲ -7.31M | ▼ -9.71M | ▼ -9.85M | ▼ -17.65M | ▼ -262.57M | ▲ -15.38M |
Common Stock Issued | 3.80M | ▼ 1.40M | ▼ 321.00K | ▲ 853.00K | ▼ 662.00K | ▼ 0.00 | 0.00 |
Common Stock Repurchased | 154.84M | ▼ 0.00 | ▼ -68.00K | ▼ -69.00K | ▼ -88.00K | ▲ 2.03M | ▼ 0.00 |
Dividends Paid | -183.00M | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -35.54M | ▲ -1.39M | ▼ -1.89M | ▼ -21.36M | ▲ -5.00M | ▲ 161.74M | ▼ -7.81M |
Net Cash Used Provided By Financing Activities | -218.92M | ▲ -7.30M | ▼ -11.28M | ▼ -30.35M | ▲ -22.17M | ▼ -100.83M | ▲ -23.16M |
Effect Of Forex Changes On Cash | 534.00K | ▼ -1.28M | ▲ 590.00K | ▼ 178.00K | ▼ -3.74M | ▲ 201.00K | ▼ -165.00K |
Net Change In Cash | 46.59M | ▼ -64.24M | ▲ 63.47M | ▼ -53.88M | ▼ -60.66M | ▲ 3.50M | ▼ -47.49M |
Cash At End Of Period | 218.78M | ▼ 152.82M | ▲ 347.12M | ▼ 256.74M | ▼ 35.23M | ▲ 99.11M | ▼ 51.62M |
Cash At Beginning Of Period | 172.19M | ▲ 217.06M | ▲ 283.65M | ▲ 310.62M | ▼ 95.89M | ▼ 95.61M | ▲ 99.11M |
Operating Cash Flow | 259.65M | ▼ -50.89M | ▲ 105.96M | ▼ 63.26M | ▼ -23.29M | ▲ 135.82M | ▼ -4.41M |
Capital Expenditure | -20.02M | ▲ -4.77M | ▼ -31.80M | ▲ -19.25M | ▲ -11.47M | ▼ -31.69M | ▲ -19.76M |
Free Cash Flow | 239.63M | ▼ -55.66M | ▲ 74.16M | ▼ 44.01M | ▼ -34.76M | ▲ 104.13M | ▼ -24.17M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)